Simon James Harrison
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 0.5%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 169
- Multiple Myeloma Research and Treatments 156
- Oncology 109
- CAR-T cell therapy research 40
- Peptidase Inhibition and Analysis 23
- Cancer Treatment and Pharmacology 18
- Co-authors
- Henry Miles Prince (70 shared papers)Hang Quach (52 shared papers)Paul Joseph Neeson (20 shared papers)Mark J. Bishton (8 shared papers)David Ritchie (30 shared papers)Benjamin W. Teh (26 shared papers)Monica A. Slavin (28 shared papers)Mark John Smyth (6 shared papers)
- Journals
- Blood (52 papers)British Journal of Haematology (14 papers)Haematologica (8 papers)Bone Marrow Transplantation (6 papers)The Lancet Oncology (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Simon James Harrison
268 papers receiving 8.8k citations
Simon James Harrison's Hit Papers
Peers
Comparison fields: 5 of 138
- Hematology 3.9k
- Oncology 3.7k
- Genetics 719
- Immunology 1.2k
- Molecular Biology 3.6k
Countries citing papers authored by Simon James Harrison
This map shows the geographic impact of Simon James Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon James Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon James Harrison more than expected).
Fields of papers citing papers by Simon James Harrison
This network shows the impact of papers produced by Simon James Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon James Harrison. The network helps show where Simon James Harrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon James Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 285 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma Hit paper breakdown → | 2023 | 544 |
| 2 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 516 |
| 3 | Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma Hit paper breakdown → | 2009 | 513 |
| 4 | Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 311 |
| 5 | 2009 | 306 | |
| 6 | 2017 | 234 | |
| 7 | 2012 | 231 | |
| 8 | 2021 | 208 | |
| 9 | 2021 | 183 | |
| 10 | 2016 | 168 | |
| 11 | FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy Hit paper breakdown → | 2024 | 162 |
| 12 | 2019 | 157 | |
| 13 | 2010 | 136 | |
| 14 | 2011 | 123 | |
| 15 | 2014 | 121 | |
| 16 | 2021 | 117 | |
| 17 | CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2024 | 116 |
| 18 | 2014 | 111 | |
| 19 | 2011 | 111 | |
| 20 | 2015 | 109 |
About Simon James Harrison
Simon James Harrison is a scholar working on Hematology, Oncology, Genetics, Immunology and Molecular Biology, having authored 285 papers that have together received 9.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (156 papers), Protein Degradation and Inhibitors (46 papers), CAR-T cell therapy research (40 papers), Peptidase Inhibition and Analysis (23 papers), Chronic Lymphocytic Leukemia Research (22 papers), Immune Cell Function and Interaction (19 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Cancer Treatment and Pharmacology (18 papers). The work is most often cited by research in Hematology (3.9k citations), Oncology (3.7k citations), Genetics (719 citations), Immunology (1.2k citations) and Molecular Biology (3.6k citations). Simon James Harrison has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Henry Miles Prince, Hang Quach, Paul Joseph Neeson, Mark J. Bishton, David Ritchie, Benjamin W. Teh, Monica A. Slavin, Mark John Smyth, Leon James Worth and A. Keith Stewart. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Bone Marrow Transplantation and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.